https://doi.org/10.1016/j.celrep.2017.02.074
A
Amrita M. Nargund
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
3.2K
Citations
15
h-index
15
i10-index
Amrita M. Nargund is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Chromatin Remodeling and Cancer & Renal and related cancers & Renal cell carcinoma treatment. The author has an h-index of 15, co-authored 18 publications.
ORCID: 0000-0001-6898-4251Papers by this author
worksThe SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma
2017 · Cell Reports · 215 citations
SETD2 loss perturbs the kidney cancer epigenetic landscape to promote metastasis and engenders actionable dependencies on histone chaperone complexes
2022 · Nature Cancer · 74 citations
https://doi.org/10.1038/s43018-021-00316-3
The C. elegans CCAAT-Enhancer-Binding Protein Gamma Is Required for Surveillance Immunity
2016 · Cell Reports · 52 citations
https://doi.org/10.1016/j.celrep.2016.01.055
PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma
2023 · Nature Cell Biology · 23 citations
https://doi.org/10.1038/s41556-023-01122-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat